F2 and kidney disorder: Identification of these sex-based differences in PT gene expression (enabled by use of scRNAseq which can capture transcripts localized to the mitochondria and cytosol), may provide insights into the well-recognized, but previously unexplained sexual dimorphism observed in most kidney diseases.